American pharmaceutical company From Wikipedia, the free encyclopedia
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Its headquarters are in South Boston, Massachusetts. It has three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Company type | Public company |
---|---|
Industry |
|
Founded | 1989 |
Headquarters | Boston, Massachusetts, U.S. |
Key people | |
Products | Pharmaceuticals |
Revenue | US$9.87 billion (2023) |
US$3.83 billion (2023) | |
US$3.62 billion (2023) | |
Total assets | US$22.7 billion (2023) |
Total equity | US$17.6 billion (2023) |
Number of employees | c. 5,400 (2023) |
Website | vrtx |
Footnotes / references [1][2] |
Vertex was founded in 1989 by Joshua Boger[3] and Kevin J. Kinsella[4] to "transform the way serious diseases are treated."[5]
Barry Werth described the company in his 1994 book, The Billion-Dollar Molecule.[4] His 2014 book, The Antidote: Inside the World of New Pharma, described the company's development over the next20 years.[6]
By 2004, its productwere mostly for viral infections, inflammatory and autoimmune disorders, and cancer.[7]
In 2009, the company had about 1,800 employees, including 1,200 in the Boston area.[3] By 2019 there were about 2,500 employees.[8]
The Cystic Fibrosis Foundation invested $150 million in the company to encourage development of drugs for Cystic Fibrosis. In 2014 it sold the rights to the royalties of the drugs for $3.3 billion. [9] The drug, Trikafta, could extend the lives of some young patients by up to 45 years. In the USA, it costs $300,000 per patient, per year. Because it is so expensive only 12% of people in the world with Cystic Fibrosis get it.
It has a new painkiller drug which is not dangerous. It plans to market it and replace the opioid painkillers which have killed many people in the USA.
in 2019 the company made $4.2 billion. In 2023 it made $9.9 billion.[10]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.